8 mg/2 mg bottle (30 count)
Indication: Buprenorphine and naloxone sublingual tablet contains buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, and is indicated for the maintenance treatment of opioid dependence.
Buprenorphine and naloxone sublingual tablet should be used as part of a treatment plan that includes counseling and psychosocial support.
Please see full Prescribing Information for more information.
Markings: Uncoated, round, biconvex, orange, sublingual tablets, debossed with ‘970’ on one side and plain on other side.
Storage and Handling: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59 and 86°F).